Return On Equity of ImmunoGen, Inc. from 30 Jun 2015 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ImmunoGen, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2023.
  • ImmunoGen, Inc. Return On Equity for the quarter ending 30 Sep 2023 was -22%, a 71% increase year-over-year.
  • ImmunoGen, Inc. annual Return On Equity for 2022 was -100%, a 1.6% decline from 2021.
  • ImmunoGen, Inc. annual Return On Equity for 2021 was -99%, a 90% increase from 2020.
  • ImmunoGen, Inc. annual Return On Equity for 2020 was -983%, a 709% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ImmunoGen, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -22% +54% +71% 01 Jul 2023 30 Sep 2023
Q2 2023 -77% -9.9% -15% 01 Apr 2023 30 Jun 2023
Q1 2023 -136% -69% -104% 01 Jan 2023 31 Mar 2023
Q4 2022 -100% -1.6% -1.6% 01 Oct 2022 31 Dec 2022
Q3 2022 -76% +10% +12% 01 Jul 2022 30 Sep 2022
Q2 2022 -67% +40% +37% 01 Apr 2022 30 Jun 2022
Q1 2022 -67% +103% +61% 01 Jan 2022 31 Mar 2022
Q4 2021 -99% +885% +90% 01 Oct 2021 31 Dec 2021
Q3 2021 -86% -278% -145% 01 Jul 2021 30 Sep 2021
Q2 2021 -107% -254% -172% 01 Apr 2021 30 Jun 2021
Q1 2021 -170% -322% -211% 01 Jan 2021 31 Mar 2021
Q4 2020 -983% -1145% -709% 01 Oct 2020 31 Dec 2020
Q3 2020 192% -160% -45% 01 Jul 2020 30 Sep 2020
Q2 2020 147% -1707% -92% 01 Apr 2020 30 Jun 2020
Q1 2020 153% +735% 01 Jan 2020 31 Mar 2020
Q4 2019 161% +771% 01 Oct 2019 31 Dec 2019
Q3 2019 353% +1037% 01 Jul 2019 30 Sep 2019
Q2 2019 1855% +1068% +136% 01 Apr 2019 30 Jun 2019
Q1 2019 -583% -721% -521% 01 Jan 2019 31 Mar 2019
Q4 2018 -610% -692% -846% 01 Oct 2018 31 Dec 2018
Q3 2018 -685% -762% -985% 01 Jul 2018 30 Sep 2018
Q2 2018 786% +718% +1053% 01 Apr 2018 30 Jun 2018
Q1 2018 138% +30% +28% 01 Jan 2018 31 Mar 2018
Q4 2017 82% -75% -48% 01 Oct 2017 31 Dec 2017
Q3 2017 77% -160% -67% 01 Jul 2017 30 Sep 2017
Q2 2017 68% -382% -85% 01 Apr 2017 30 Jun 2017
Q1 2017 108% -4547% -98% 01 Jan 2017 31 Mar 2017
Q4 2016 157% +688% 01 Oct 2016 31 Dec 2016
Q3 2016 237% +394% 01 Jul 2016 30 Sep 2016
Q2 2016 451% +556% 01 Apr 2016 30 Jun 2016
Q1 2016 4655% 01 Jan 2016 31 Mar 2016
Q4 2015 -531% 01 Oct 2015 31 Dec 2015
Q3 2015 -157% 01 Jul 2015 30 Sep 2015
Q2 2015 -105% 01 Apr 2015 30 Jun 2015

ImmunoGen, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -100% -1.6% -1.6% 01 Jan 2022 31 Dec 2022
2021 -99% +885% +90% 01 Jan 2021 31 Dec 2021
2020 -983% -1145% -709% 01 Jan 2020 31 Dec 2020
2019 161% +771% 01 Jan 2019 31 Dec 2019
2018 -610% -692% -846% 01 Jan 2018 31 Dec 2018
2017 82% -75% -48% 01 Jan 2017 31 Dec 2017
2016 157% +262% 01 Jan 2016 31 Dec 2016
2015 -105% 01 Jul 2014 30 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.